Tesamorelin 10mg: Vial Size, Reconstitution and Research Storage

Search for “tesamorelin 10mg” and you will find a range of listings, from single vials to multi-vial bundles. The 10mg configuration is one of the most common vial sizes for research-grade tesamorelin. Understanding how the 10mg vial works, how the concentration is calculated, and how the reconstituted solution should be stored is essential for laboratory work.

This guide explains what a tesamorelin 10mg vial is, how the concentration is calculated after reconstitution, how the vial should be stored and handled, and what documentation to verify before sourcing.

What a tesamorelin 10mg vial is

Tesamorelin is a synthetic GHRH analog that binds to GHRH receptors in the pituitary, promoting the pulsatile release of endogenous growth hormone. It is FDA-approved in the United States under the brand name Egrifta to reduce excess abdominal fat in adults with HIV-associated lipodystrophy, but it is not licensed in the UK or the EU. The EU marketing authorisation application was withdrawn in 2012 after the CHMP could not conclude on a positive benefit-risk balance.

A 10mg vial contains 10 milligrams of lyophilised tesamorelin powder. The powder is stable for extended periods when stored correctly, but it must be reconstituted with a diluent before laboratory use. The Alta Peptides tesamorelin product page lists the available configurations and documentation.

The pooled Phase 3 analysis published in the Journal of Clinical Endocrinology and Metabolism evaluated tesamorelin at a dose of 2mg per day in a clinical setting. The 10mg vial is not a clinical dose but a research vial size that provides flexibility in concentration.

Concentration after reconstitution

The concentration of the reconstituted solution depends on the volume of diluent added. The calculation is the mass of peptide divided by the volume of diluent.

Concentration (mg/mL) = Mass of peptide (mg) / Volume of diluent (mL)

For a 10mg vial, the concentration for common diluent volumes is as follows.

The Alta Peptides reconstitution calculator works out the concentration for any combination of mass and volume.

Reconstitution and handling

The reconstitution process for a 10mg tesamorelin vial is the same as for any other lyophilised peptide. The Alta Peptides bacteriostatic water product page lists the available diluent configurations.

The key steps are: calculate the volume of diluent needed, add it slowly down the inside wall of the vial, swirl gently to dissolve the powder, and store the resulting solution correctly. Do not shake the vial, as this can cause foaming and damage the peptide structure.

The Alta Peptides guide to reconstituting peptides provides a step-by-step walkthrough of the process.

Storage after reconstitution

Once reconstituted, the tesamorelin solution has a shorter shelf life than the lyophilised powder. The Alta Peptides guide to lyophilised peptide stability explains how temperature and humidity affect the product over time.

The Bachem handling and storage guidelines for peptides explain the temperature ranges that maintain peptide integrity. Reconstituted solutions are typically stored at 2 to 8 degrees Celsius and used within a defined window. Bacteriostatic water extends the shelf life compared with sterile water because it contains a preservative.

The researcher’s verification checklist

1. Lot-specific certificate of analysis

A certificate of analysis (COA) is only meaningful if it corresponds to the exact lot you are buying. The COA should list the lot number, the testing laboratory, the report ID, the date the sample was received, and the date the results were published. The Alta Peptides certificates page collects the reports for all products.

2. Measured content, not just label claim

The label states the nominal mass, but the actual mass in the vial may differ slightly. The COA reports a measured content value that reflects the actual fill. For precise work, use the measured content rather than the label claim.

3. Complete analytical panel

A certificate that lists only “purity: 99%” is incomplete. The useful fields are identity by mass spectrometry, purity by HPLC, measured content, endotoxin, and sterility.

4. Research-use-only boundary

The listing should not publish dosing, administration, or human-use content. A supplier that maintains the boundary consistently is easier to trust than one that publishes human-use content alongside the RUO label.

How Alta Peptides approaches tesamorelin documentation

Alta Peptides is a UK-based research peptide supplier that publishes lot-specific documentation for each product configuration. The growth hormone category organises the peptides studied in this research area.

Comparing tesamorelin vial sizes

Common questions about tesamorelin 10mg

What concentration do I get from a 10mg vial?

The concentration depends on the volume of diluent added. With 1ml of diluent, the concentration is 10mg/ml. With 2ml, it is 5mg/ml. With 5ml, it is 2mg/ml.

Should I use the label claim or the measured content?

For precise work, use the measured content from the certificate of analysis. The label states the nominal mass, but the actual mass in the vial may differ slightly.

How should I store a reconstituted tesamorelin solution?

The GenScript storage guide recommends storing reconstituted peptides at 2 to 8 degrees Celsius and using them within a defined window. Bacteriostatic water extends the shelf life compared with sterile water.

What should a tesamorelin COA show?

A complete COA should report identity by mass spectrometry, purity by HPLC with the method stated, measured content or assay value, endotoxin testing, and sterility testing. It should also include the lot number, the testing laboratory’s name, the report ID, and the dates of sample receipt and result reporting.

How do I verify that a COA is real?

Check that the testing laboratory is named and that the report ID can be cross-referenced. Some laboratories publish verification portals where a report ID can be entered to confirm the document’s authenticity.

What should I do if a supplier’s listing makes health claims?

Treat it as a disqualifying signal. Health claims on a research peptide listing are the exact pattern that regulators have cited in enforcement actions.